Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Nathan

Chest

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Chest|June 8, 2020
POINT: Should Every Patient With Idiopathic Pulmonary Fibrosis Be Referred for Transplant Evaluation? YesSteven D Nathan
Chest|June 8, 2020
Rebuttal From Dr NathanSteven D Nathan
Chest|March 15, 2005
Lung transplantation: disease-specific considerations for referralSteven D Nathan
Chest|November 24, 2005
Therapeutic intervention: assessing the role of the international consensus guidelinesSteven D Nathan
Chest|February 4, 2015
The future of lung transplantationSteven D Nathan
Chest|June 14, 2016
Rebuttal From Drs King and NathanChristopher S King, Steven D Nathan
Chest|October 16, 2002
Telesupport: just reach out and touch someoneSteven D Nathan, Scott D Barnett
Chest|June 14, 2016
POINT: Should All Patients With Idiopathic Pulmonary Fibrosis, Even Those With More Than Moderate Impairment, Be Treated With Nintedanib or Pirfenidone? YesChristopher S King, Steven D Nathan
Chest|August 5, 2015
Organ Donors: Making the Most of What Is OfferedSteven D Nathan, Christopher S King
Chest|July 9, 2023
ResponseSteven D Nathan, Aaron B Waxman
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Chest|June 8, 2020
POINT: Should Every Patient With Idiopathic Pulmonary Fibrosis Be Referred for Transplant Evaluation? YesSteven D Nathan
Chest|June 8, 2020
Rebuttal From Dr NathanSteven D Nathan
Chest|March 15, 2005
Lung transplantation: disease-specific considerations for referralSteven D Nathan
Chest|November 24, 2005
Therapeutic intervention: assessing the role of the international consensus guidelinesSteven D Nathan
Chest|February 4, 2015
The future of lung transplantationSteven D Nathan
Chest|June 14, 2016
Rebuttal From Drs King and NathanChristopher S King, Steven D Nathan
Chest|October 16, 2002
Telesupport: just reach out and touch someoneSteven D Nathan, Scott D Barnett
Chest|June 14, 2016
POINT: Should All Patients With Idiopathic Pulmonary Fibrosis, Even Those With More Than Moderate Impairment, Be Treated With Nintedanib or Pirfenidone? YesChristopher S King, Steven D Nathan
Chest|August 5, 2015
Organ Donors: Making the Most of What Is OfferedSteven D Nathan, Christopher S King
Chest|July 9, 2023
ResponseSteven D Nathan, Aaron B Waxman
Pageof 5